Zhekebekov Kuanysh Kairatovich
PhD (Doctor of Philosophy), Head of Laboratory.
Specialist in the field of biotechnology. Author of more than 50 scientific publications, including 12 papers with a non-zero impact factor indexed in the Web of Science and Scopus databases. Holds 4 authorship certificates for developments. In 2020, was awarded a Letter of Appreciation from the Ministry of Education and Science of the Republic of Kazakhstan for contributions to the development and production of the QazVac vaccine against the COVID-19 coronavirus infection.In 2021, was awarded the “Halyk Algysy” (People’s Gratitude) Medal, and in 2024 received the “Excellence in Healthcare” Medal. Has participated in more than 50 trainings and educational programs. In 2024, completed advanced training courses at LLP “National Scientific Center for Especially Dangerous Infections” (NNCOOI) in Almaty, Republic of Kazakhstan, on the topic “Biosafety, Epidemiology, and Microbiology of Infectious Diseases of Pathogenicity Group II”, with a total duration of 630 hours.
ORCID ID – https://orcid.org/0000-0002-7801-6198
Scopus ID – 57218866785
Web of Science Researcher ID – ABA-2145-2020
+7(72636)7-22-22
Project executor:
| BR25293294-OT-25 | A vaccine against brucellosis based on genomic technologies. |
| BR28712529-OT-25 | Development of tools for the specific prevention and diagnosis of monkeypox. |
Research Areas of the Laboratory:
- Quality and safety control of biological products and test systems;
- Physicochemical analysis of biological products;
- Evaluation of biological activity;
- Assessment of stability and composition during storage;
- Evaluation of the efficacy of biological products;
- Assessment of immunobiological indicators of biological products;
- Conducting studies to determine the safety and immunogenicity of vaccine preparations;
- Conducting preclinical and clinical trials of new biological products.
Innovative Developments of the Laboratory:
- Inactivated influenza A/H5N1 vaccine and Refluvac®;
- Trivalent split vaccine against seasonal influenza;
- Tuberculosis vaccine for cattle;
- ELISA test system for detection of antibodies to SARS-CoV-2 coronavirus.
Main Publications of the Laboratory: